Facebook
Twitter
LinkedIn
ForwardMiami Cancer Institute Global Summit on Immunotherapies for Hematologic Malignancies, Fourth Annual
Live Symposium | 12.25 Cat. 1
March 10-11, 2023 | Friday-Saturday
The Ritz-Carlton, Coconut Grove, Miami, Florida
Given the increasing frequency of hematologic malignancies, complexities of treatments with novel agents and particularly with immunotherapeutic approaches, there is a need to provide an opportunity for oncologists, hematologists, oncology nurses and pharmacists to engage in thoughtful discussions with experts in these fields. In addition, there is emerging data about the biology of these malignancies impacting optimal management of patients with these disorders. Clinical decision making and management therefore have become more complex.
This two-day symposium has been designed to provide an overview and opportunity to learn about the most recent advances in the treatment of leukemia, lymphoma, multiple myeloma and stem cell transplantation by novel immunotherapies and treatment combinations. Updates on evolving immunologically and molecular based system therapies will be profiled and discussed.
Agenda
Friday, March 10 - 6.25 Cat. 1
| 7:30 a.m. | Registration, Breakfast, and Visit Exhibits |
| 8:30 a.m. | Welcome and Introductions Guenther Koehne, M.D., Ph.D. |
| Acute Myeloid Leukemia | |
| 8:45 a.m. | Acute Myeloid Leukemia in 2023 Richard Stone, M.D. |
| 9:15 a.m. | Targeted Therapies in Acute Myeloid Leukemia Eytan Stein, M.D. |
| 9:45 a.m. | Myelofibrosis: Current and Emerging Treatments Raajit Rampal, M.D. |
| 10:15 a.m. | Break and Visit Exhibits |
| Acute Lymphoid Leukemia | |
| 10:45 a.m. | Adult ALL: Frontline Treatment (R)Evolution! Wendy Stock, M.D. |
| 11:15 a.m. | ALL: New Treatment Options for Relapsed Disease Nitin Jain, M.D. |
| 11:45 a.m. | Lunch and Visit Exhibits |
| 12:15 p.m. | Product Theater |
| 12:45 p.m. | Break and Visit Exhibits |
| Multiple Myeloma | |
| 1:15 p.m. | Treatments for Multiple Myeloma Paul Richardson, M.D. |
| 1:45 p.m. | Targeted Therapies for Myeloma Adam Cohen, M.D. |
| 2:15 p.m. | Auto SCT vs. CAR T in Multiple Myeloma Gunjan Shah, M.D. |
| 2:45 p.m. | Break and Visit Exhibits |
| Non-Hodgkin's Lymphoma and Hodgkin's Disease | |
| 3:15 p.m. | Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma Andrew M. Evens, D.O., MBA |
| 3:45 p.m. | Updates on Treatment Approaches for Primary (CNS) Lymphoma Craig Sauter, M.D. |
| 4:15 p.m. | Updates on Management of Early- and Advanced-Stage Disease of Hodgkin's Disease Alison Moskowitz, M.D. |
| 4:45 p.m. | Questions and Answers Moderator: Guenther Koehne, M.D., Ph.D. |
| 5:15 p.m. | Adjourn |
Saturday, March 11 - 6 Cat. 1
| 8:00 a.m. | Registration and Breakfast |
| Allogeneic Stem Cell Transplants | |
| 8:30 a.m. | Prevention and Treatment of Relapse After Allogeneic Transplantation Robert Soiffer, M.D. |
| 9:00 a.m. | Novel Treatment Approaches of Graft-Versus-Host Disease Corey Cutler, M.D. |
| 9:30 a.m. | CD34+-Selected Allografts as Platform for Adoptive Immunotherapy Guenther Koehne, M.D., Ph.D. |
| 10:00 a.m. | Lessons in Diversity from Investigating Cord Blood as an Alternative Stem Cell Source Juliet Barker, MBBS, FRACP |
| 10:30 a.m. | Break and Visit Exhibits |
| CAR T-Cell Therapies | |
| 11:00 a.m. | Next Steps in CAR T-Cell Therapies Michel Sadelain, M.D., Ph.D |
| 11:30 a.m. | CAR T-Cell Therapies for AML Siddhartha Mukherjee, M.D. |
| 12:00 p.m. | Do We Need a CAR T Registry? Marcelo Pasquini, M.D. |
| 12:30 p.m. | Lunch and Visit Exhibits |
| 1:00 p.m. | Product Theater |
| 1:30 p.m. | Break and Visit Exhibits |
| 2:00 p.m. | The Role of the Intestinal Microbiome in Cancer Immunotherapy Marcel van den Brink, M.D., Ph.D. |
| 2:30 p.m. | Immunotherapeutic Approaches to Undruggable Leukemia Targets David Scheinberg M.D., Ph.D. |
| 3:00 p.m. | LYT-200, a Fully Human Anti-Galectin-9 Antibody as Investigational Therapy for Relapsed/Refractory AML/High-Risk MDS |
| 3:30 p.m. | Lung Stem Cells for Lung Regeneration Yair Reisner, Ph.D. |
| 4:00 p.m. | Adjourn |
NOTE: Schedule subject to change.
Rooms can be booked at the discounted group rate mentioning the MCI immunotherapy symposium.
Miami might stimulate the mind for glitter and glamour, but it is the city’s Coconut Grove district that serves up its cultural soul. Art galleries, museums, boutiques and restaurants beckon visitors to this historic Florida neighborhood, along with The Ritz-Carlton Coconut Grove, Miami, a hotel destined to enchant every guest with a truly unique hospitality experience. Inspired by the peacock hues of blue, violet and green, the hotel exquisitely blends in to the lush surroundings of this Biscayne Bay artist enclave, making it a work of art itself. Enjoy dining that exemplifies Miami’s diverse mix of cultural flavors. Find inner tranquility with a customized spa experience. Or let the glow of a fire pit and the comfort of an oversized couch make an evening on our Courtyard Fountain Terrace all the more memorable. The Ritz-Carlton Coconut Grove, Miami is also just minutes from first-class shopping and dining in Brickell, Miami.
Travel
The drive time between The Ritz-Carlton, Coconut Grove and Miami International Airport (MIA) is around 20 minutes and covers a distance of around 6.5 miles.
Valet Parking Rates are $25 Daily, $45 overnight.
Symposium Director
Deputy Director
Chief, Blood and Marrow Transplant and Hematologic Oncology
Miami Cancer Institute
Miami, Florida
Faculty
Director
Cord Blood Transplant Program
Memorial Sloan Kettering Cancer Center
New York, New York
Associate Professor, Medicine
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania
Medical Director, Adult Stem Cell Transplant Program
Associate Professor of Medicine, Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts
Associate Vice Chancellor, Clinical Innovation & Data Analytics
Rutgers Biomedical and Health Sciences
Associate Director (Clinical Services)
Rutgers Cancer Institute of New Jersey
System Director of Medical Oncology, and Oncology Lead for
RWJBarnabas-Rutgers Medical Group, RWJBarnabas Health
Professor of Medicine, Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey
Associate Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
Houston, Texas
Medical Oncologist
Memorial Sloan Kettering Cancer Center
New York, New York
Professor of Medicine
Columbia University Irving Medical Center
New York, New York
Medical Oncologist
Medical College of Wisconsin
Milwaukee, Wisconsin
Associate Member
Clinical Director
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, New York
Professor
Department of Stem Cell Transplantation
Division of Cancer Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas
Clinical Program Leader and Director
of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Director
Center for Cell Engineering
Memorial Sloan Kettering Cancer Center
New York, New York
Hematology and Medical Oncology
Director, Blood and Marrow Transplant Program
Cleveland Clinic Main Campus
Cleveland, Ohio
Director, Experimental Therapeutics Center
Deputy Director, SKI for Therapeutic Discovery
Memorial Sloan Kettering Cancer Center
New York, New York
Hematologic Oncologist
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center
New York, New York
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Assistant Attending Physician
Director, Program for Drug Development in Leukemia
Leukemia Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Anjuli Seth Nayak Professor of Leukemia Research
Section Hematology/Oncology
University of Chicago Medicine and Comprehensive Cancer Center
Chicago, Illinois
Chief of Staff, Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Medical Oncologist
Head, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
New York, New York
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 12.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for a total of 12.25 credit hours, CE Broker Course #20-936211 and 20-936215, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has been approved for 12 credits for Nurse Practitioners and Nurses, 12.25 for Pharmacists and Techs and 12.2 for Laboratory Personnel in Hematology. Baptist Health South Florida CE Broker Provider #50-182.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts CEs accredited by the ACCME. Individuals are responsible for checking with the AANPCB for further guidelines.
AMA PRA Category 1 Credits™ claimed by physicians attending live events certified and organized in the United States for AMA PRA Category 1 Credits™ can be claimed through the agreement on mutual recognition of credits between UEMS and AMA, considered as being equal to the European Continuous Medical Education Credits (ECMEC©) granted by the UEMS. One AMA PRA Category 1 Credit™ is equivalent to one (1) hour of European EACCME Credit (ECMEC©). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 12.25 AMA PRA Category 1 Credit™
- 12.25 General certificate of attendance
- 12.25 Florida Board of Laboratory Personnel
- 12.25 Nurse Practitioners
- 12.25 Florida Board of Nursing
- 12.25 Florida Board of Pharmacy
We gratefully acknowledge the following exhibitors:
Abbvie
Abbvie/Pharmacyclics
Acrotech Biopharma
Adaptive Biotech
ADC Therapeutics
Alexion
Amgen
Apellis Pharmaceuticals
Astellas Oncology
AstraZeneca Pharmaceuticals
Atara Biotherapeutics
Beigene
Blueprint Medicines
Bristol-Myers Squibb
CTI Biopharma
EUSA/Recordati Rare Diseases
Genentech
Gift of Life Marrow Registry
GlaxoSmithKline
Incyte
Janssen Oncology
Jazz Pharmaceuticals
Kadmon, a Sanofi Company
Karyopharm Therapeutics
Kite Pharma
Legend Biotech
Lilly Oncology
Miami Cancer Institute
Morphosys
Neogenomics
Novartis Hematology
Omeros Pharma
Pfizer Oncology
Pharmacosmos Therapeutics
Protagonist Therapeutics
Rigel Pharmaceuticals
Sanofi Genzyme
Seagen
Stemline Therapeutics
Taiho Oncology
Takeda Oncology
We gratefully acknowledge the following first-time exhibitors:
Acrotech Biopharma
EUSA/Recordati Rare Diseases
Gift of Life Marrow Registry
Legend Biotech
Rigel Pharmaceuticals
Stemline Therapeutics
Price
⚠ | COVID-19 Protocols Notice for All Attendees, Exhibitors and VendorsSelf-screening is required for all in-person attendees. If you have any symptoms of respiratory illness, you must refrain from attending in person. Please be sure to read our COVID Protocols for all in-person education prior to registering for this activity. |